Refractory Hypoglycaemia in Hepatocellular Carcinoma Treated with TACE Leading to Tumour Lysis Syndrome- A Double Trouble
Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer. Hypoglycaemia is a well-established paraneoplastic manifestation of HCC. Cytoreduction by surgery or Transarterial Chemoembolisation (TACE) has been effective treatment options in such cases when conservative treatment f...
Main Authors: | Saurabh kumar, Ishita B Sen, Vivek Vij, Ashish Singhal, Ajitabh Srivastava |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2022-01-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/15923/52274_CE(Ra1)_F(SS)_PF1(SC_SS)_PFA(SC_KM)_PN(KM).pdf |
Similar Items
-
Transcatheter arterial chemoembolisation (TACE) plus S-1 for the treatment of BCLC stage B hepatocellular carcinoma refractory to TACE
by: Wu-Kui Huang, et al.
Published: (2017-01-01) -
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
by: Baur J, et al.
Published: (2016-06-01) -
A retrospective pilot study of transarterial chemoembolisation using camrelizumab-eluting Callisphere beads for unresectable hepatocellular carcinoma
by: Xiaonan Shi, et al.
Published: (2023-11-01) -
Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation
by: Gauri Mishra, et al.
Published: (2020-05-01) -
Barcelona Clinic Liver Cancer: A Narrative Review
by: Nitin Kumar Patel, et al.
Published: (2023-07-01)